CompletedNot Applicable

Function-Preserving Surgery for Parotid Tumors: Intracapsular Versus Superficial Parotidectomy; A Randomized Clinical Trial.

Egypt120 participantsStarted 2024-05-01

Plain-language summary

Benign parotid gland tumors, such as pleomorphic adenoma and Warthin tumors, constitute the majority of salivary gland neoplasms. Surgical excision remains the primary treatment, traditionally achieved through superficial parotidectomy (SP). However, SP may lead to complications such as facial nerve dysfunction, Frey's syndrome, and aesthetic concerns. Intracapsular parotidectomy (ICP), a minimally invasive alternative, aims to minimize surgical morbidity while preserving oncologic safety. This study aimes to compare intracapsular parotidectomy and superficial parotidectomy in terms of operative efficiency, complications, facial nerve preservation, and tumor recurrence for benign parotid tumors.

Who can participate

Age range20 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age between 20 and 65 years, * radiologically and clinically confirmed benign parotid tumor * tumor confined to the superficial or deep lobe without evidence of facial nerve involvement. Exclusion Criteria: * suspicion of malignancy based on imaging or fine-needle aspiration cytology (FNAC) * recurrent parotid tumors * previous parotid surgery * facial nerve dysfunction preoperatively * comorbidities precluding surgery.

What they're measuring

Operative time

Timeframe: Intraoperatively

Blood Loss

Timeframe: Introperative

recurrence rate

Timeframe: 6 months postopeartively

Trial details

NCT IDNCT07185542

SponsorAl-Azhar University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05-01

View on ClinicalTrials.gov More Parotid Tumors trials